News

Ruth Sanger Orator BLOOD 2021

We congratulate again, Linley Bielby who was the BLOOD 2021 ANZSBT Ruth Sanger orator. The Ruth Sanger Award is the highest award of the Society and is made in recognition of a significant contribution to the field of transfusion medicine.

As BLOOD 2021 was a virtual meeting, we were unable to present Linley with her medal physically. We sincerely thank Professor Erica Wood who kindly presented the Ruth Sanger medal to Linley on behalf of the Society at a small gathering. Congratulations Linley on your well-deserved award!

CSL Behring/ANZSBT PhD Scholarship 2022

We congratulate Suelyn Van den Helm who has been awarded the CSL Behring/ANZSBT PhD Scholarship for 2022.

Suelyn’s project title is “Towards personalised blood product therapy after cardiopulmonary bypass in neonates and infants”.  She explains:

“Annually in Australia, approximately 3000 babies are born with severe heart problems. These babies require surgery which uses a heart-lung support known as cardiopulmonary bypass (CPB). While CPB has improved survival rates, CPB is associated with a risk of bleeding and death. Current approaches to manage bleeding in CPB include transfusing high volumes of blood products, however this can lead to heart failure. There are now several targeted low volume haemostatic agents available, however, as the mechanisms driving bleeding in CPB are unknown, there is little evidence for the clinical use of these agents. My project is a 3-year study of 150 babies undergoing CPB at The Royal Children’s Hospital in Melbourne, the largest children’s heart surgical centre in Australia. Blood samples and detailed clinical data will be collected using a protocol established and published by our research team. Once we understand why bleeding occurs in some babies, we can trial new targeted therapies including CSL products RiaSTAP®, Prothrombinex®-VF, Biostate® and MonoFIX®-V, and improve outcomes. This will lead to improvements in bleeding management strategies and enable us to determine personalised therapy for these vulnerable babies.”

We wish Suelyn all the best in her degree.

 

Abstract Submission for BlOOD 2022 is open

BLOOD 2022 Meeting

Sydney Convention and Exhibition Centre
11-14 September 2022

 

Abstract submission for BLOOD 2022 is now open and we encourage you to make your own contribution to the educational content of the Meeting by submitting your research, case study or similar as an abstract.

Just a reminder that abstract submission will close on Wednesday 18 May.

To submit your abstract, please click here

HSANZ PhD and Fellowship Scholarships

Applications are now open for the 2022 HSANZ scholarships and awards:

For more information visit: https://www.hsanz.org.au/scholarships-and-awards

 

ANZSBT Evolve Recommendations

ANZSBT is proud to announce the release of the top 5 Evolve recommendations on low value practices.

The list of low value practices was first identified by the ANZSBT Council and condensed to the top-5 recommendations after rigorous research. The list was subjected to an extensive review and consultation process that involved RACP-affiliated specialty societies and other key colleges via the Choosing Wisely program.

These recommendations are now listed in the ANZSBT Position and Consensus Statements website page here.

The recommendations were also cited in a recent interview by Dr Anastazia Keegan on ABC Online, an RACP media release and The Limbic.

ANZSBT Research Grant 2022

ANZSBT is excited to announce that the 2022 Research Grant is now open for applications with a closing date of Sunday 27th March 2022.

The ANZSBT Research Fund supports research in transfusion and related fields and is offering a total of $75,000, comprising either a single grant of $75,000 or smaller grants totalling $75,000 in 2022.

The Fund is available to Australian and New Zealand investigators at all levels of their careers who are undertaking basic, clinical and translational research in transfusion.

The Invitation and Terms of Reference as well as the application form can be found here…. under the ANZSBT Research Fund tab.

RACP MyCPD program upgrade – enhanced functionality

The RACP MyCPD program has introduced changes that will assist participants with recording their CPD.

Please contact the CPD Team if you have any questions or suggestions for future enhancements.

AU: 1300 697 227 or MyCPD@racp.edu.au

NZ: 64 4 460 8122 or MyCPD@racp.org.nz

 

ANZSBT Transfusion management of patients treated with monoclonal antibody (MAb) therapies that interfere with immunohaematology testing

The ANZSBT Transfusion Science Standing Committee has prepared an addendum to the Guidelines for transfusion and immunohaematology laboratory practice relating to Therapeutic Monoclonal Antibodies. This addendum can be found here… in our Guidelines webpage

BLOOD 2021 abstracts Internal Medicine Journal

ANZSBT is excited to announce that the BLOOD 2021 ANZSBT stream abstracts have now been published in the Internal Medicine Journal and can be viewed here..